Published in Medical Device Law Weekly, December 2nd, 2007
"The creation of cloned stem cell lines in primates is a milestone," said Bernard Siegel, executive director of the Genetics Policy Institute. "Stem cells derived in this fashion in humans could lead to cell therapies using a patient's own cells and thereby avoid the problems on immune suppression. In the future, researchers may create cloned cell lines from patients burdened by diabetes and other diseases. Such cells could be studied to determine the root causes for disease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly